• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • View the Map
  • Local Data
  • News & Updates
  • Tools & Resources
Home Tools & Resources Deeper Look: Opioids

Deeper Look: Opioids

The opioid crisis is one of the greatest public health challenges facing the U.S., causing an unprecedented surge in drug overdose deaths, and fueling the rapid rise in new Hepatitis C infections from injection drug use in communities across the country.

Share Facebook Twitter Pinterest LinkedIn

As opioid abuse rates have skyrocketed, new Hepatitis C infections have also increased. Data on HepVu show that an estimated 2.3 million Americans were living with Hepatitis C between 2013 and 2016. Though the majority, or roughly three-fourths, of all infections were among Baby Boomers (those born between 1945 and 1965), there has been a spike in new Hepatitis C infections among younger Americans.

The number of new Hepatitis C infections more than tripled from 2010 to 2016, largely reflecting infections due to the rise in injection drug use. This has created a syndemic, in which the opioid and Hepatitis C epidemics are linked – with the burden of Hepatitis C being directly exacerbated by injection drug use.

The Opioid Epidemic

In 2017, the U.S. Department of Health and Human Services (HHS) declared a public health state of emergency due to the opioid epidemic. Opioids are highly addictive and include prescription pain relievers, synthetic compounds such as fentanyl, and illegal drugs such as heroin. From 2002 to 2017, the number of deaths due to opioid abuse have more than quadrupled. The opioid epidemic’s growth even contributed to a decrease in annual U.S. life expectancy, which declined to 78.6 years in 2016 primarily due to increases in suicides and opioid-related overdose deaths.

The Syndemic

A syndemic refers to two or more interrelated epidemics that are mutually reinforcing and interact in a way that amplifies the overall burden of disease. Although not all people who abuse opioids inject drugs, people who inject drugs are at significantly higher risk of transmission of blood-borne viruses, including HIV and Hepatitis C.

Hepatitis C and HIV can be transmitted by sharing needles, syringes, water, alcohol swabs, and other equipment used to inject drugs. Nearly 75 percent of people with HIV who inject drugs are also infected with Hepatitis C. As younger Americans engage in injection drug use, there is also a greater risk of women of childbearing age contracting Hepatitis C and pregnant women exposing their babies to the virus.

The Centers for Disease Control and Prevention (CDC) recommends routine HIV and viral hepatitis screening for people who inject drugs. Additionally, prevention efforts, such as syringe service programs and substance use treatment services, can slow the growth in the number of new Hepatitis C and HIV infections due to injection drug use. By identifying new infections early, patients can be treated for HIV, or cured of Hepatitis C, and stop additional infections from occurring.

Share

Share our infographics with your networks to help raise awareness and understanding of the link between opioids and Hepatitis C.

Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn

Interactive Maps

Learn more about the opioid epidemic through indicators mapped on HepVu, and see how the epidemic impacts your community.

Opioid Prescriptions

Opioid Prescriptions

The rate of retail opioid prescriptions dispensed per 100 persons in 2017

See the Data
Narcotic Overdose Deaths

Narcotic Overdose Deaths

The rate of drug overdose-related deaths per 100,000 persons from 2013 to 2016

See the Data
Pain Reliever Misuse

Pain Reliever Misuse

The percentage of persons misusing prescription pain relievers, averaged from 2015 to 2016

See the Data

4 Ways to Use HepVu

Explore Maps

  • Explore the interactive map, customize your view, and easily print for presentations, grant applications, or other materials
Learn More

View Local Statistics

  • View local statistics for your state, and download high-impact data visualizations for your work
Learn More

Download Data

  • Download the data sets that inform HepVu’s visualizations for your own research and analysis
Learn More

Share Infographics

  • Download and share our educational infographics
Learn More

Learn From Experts

Experts weigh in on the opioid epidemic and the resulting syndemic in HepVu’s blog series.

medium

Opioids

Vu Q&A: The Opioid Epidemic and Viral Hepatitis in Appalachia

Judith Feinberg, a nationally-recognized expert on the opioid epidemic in West Virginia, Appalachia and rural America, speaks about opioids and viral hepatitis in Appalachia.

Learn More
Don-Des-Jarlais

Opioids

Addressing Increases in Hepatitis C Infections Linked to the Opioid Epidemic

Don C. Des Jarlais on an important component of the U.S. Hepatitis C epidemic that's smaller in absolute numbers but is the major source of new Hepatitis C infections: infections associated with the opioid epidemic.

Learn More
01-HepVu-Opioid-Homepage-01

Opioids

Vu Q&A: The Opioid Epidemic’s Impact on Hepatitis C in the U.S.

Heather Bradley and Ron Valdiserri speak to the new HepVu data and how the opioid epidemic changing the way we look at Hepatitis C.

Learn More
medium

Opioids

Vu Q&A: The Opioid Epidemic and Viral Hepatitis in Appalachia

Judith Feinberg, a nationally-recognized expert on the opioid epidemic in West Virginia, Appalachia and rural America, speaks about opioids and viral hepatitis in Appalachia.

Learn More
Don-Des-Jarlais

Opioids

Addressing Increases in Hepatitis C Infections Linked to the Opioid Epidemic

Don C. Des Jarlais on an important component of the U.S. Hepatitis C epidemic that's smaller in absolute numbers but is the major source of new Hepatitis C infections: infections associated with the opioid epidemic.

Learn More
01-HepVu-Opioid-Homepage-01

Opioids

Vu Q&A: The Opioid Epidemic’s Impact on Hepatitis C in the U.S.

Heather Bradley and Ron Valdiserri speak to the new HepVu data and how the opioid epidemic changing the way we look at Hepatitis C.

Learn More

For More Information

Additional information about the opioid and Hepatitis C epidemics can be found at the following resources.

U.S. Centers for Disease Control and Prevention

Opioid Overdose: Understanding the Epidemic

Learn More

National Institute on Drug Abuse

Brief description of opioids

Learn More

amfAR

Opioid & Health Indicators Database

Learn More

U.S. Centers for Disease Control and Prevention

Increase in hepatitis C infections linked to worsening opioid crisis

Learn More

Surgeon General

Facing Addition in America: The Surgeon General’s Spotlight on Opioids (PDF)

Learn More

Sign up for HepVu updates:

Footer

HepVu HepVu
Facebook Twitter
  • About
  • FAQ
  • Data Methods

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

2021 © HepVu. ALL RIGHTS RESERVED.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.